Kanamycine solution de Streptomyces kanamyceticus, 50 mg / mL dans 0,9 % NaCl, bioréactif, liquide, filtre stérile, adapté à la culture cellulaire

Code: k0254-20ml D2-231

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Kanamycin solution from Streptomyces kanamyceticus has been used: to induce deafness in neonatal ratsas an endothelial growth medium component for culturing human...


en savoir plus

Votre prix
$92.80 20ML

Non disponible en dehors du Royaume-Uni et de l'Irlande

Application

Kanamycin solution from Streptomyces kanamyceticus has been used: to induce deafness in neonatal ratsas an endothelial growth medium component for culturing human umbilical vein endothelial cells (HUVECs)as medium component for Mycobacteria Cultures and Top10 E coli cells

Biochem/physiol Actions

Mode of Action: The product acts by binding to the 70S ribosomal subunit, inhibiting translocation and eliciting miscoding. Mode of Resistance: Aminoglycoside-modifying enzymes (including acetyltransferase, phosphotransferase, nucleotidyltransferase) can alter this antibiotic, preventing its interaction with ribosomes.Antimicrobial spectrum: Kanamycin sulfate is effective against gram-negative and gram-postiive bacteria, and mycoplasma.

Caution

Solutions are stable at 37°C for approximately 5 days. Aqueous stock solutions can be stored at 2-8°C for long term storage.

General description

Kanamycin sulfate is a broad spectrum aminoglycoside-antibiotic derived from Streptomyces kanamyceticus. It is used as an additive in culture media for the isolation of group D streptococci on Kanamycin Esculin Azide Agar and for selection of transformed plant cells containing the neomycin phosphotransferase on a kanamycin-medium. Kanamycin sulfate can also be used as a selection agent for cells transformed with kanamycin B resistance gene. It is recommended for use in cell culture applications at 2 mL/L.

antibiotic activity spectrummycoplasma, Gram-positive bacteria, Gram-negative bacteria, mycobacteria
biological sourceStreptomyces kanamyceticus
concentration50 - 60 mg/mL in 0.9% NaCl
formliquid
impuritiesendotoxin, tested
InChI keySBUJHOSQTJFQJX-NOAMYHISSA-N
InChI1S/C18H36N4O11/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17/h4-18,23-29H,1-3,19-22H2/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-/m1/s1
mode of actionprotein synthesis | interferes
product lineBioReagent
Quality Level200
SMILES stringNC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O
sterility0.1 µm filtered
storage temp.2-8°C
technique(s)cell culture | plant: suitable, cell culture | mammalian: suitable
Cas Number25389-94-0
Ce produit répond aux critères suivants: